American Society of Hirudotherapy

Leech-Assisted Flap Salvage — Systematic Review of 277 Cases

Evidence base for the FDA-cleared microsurgical indication

Clinical LiteratureWhitaker et al. (2012)— MicrosurgeryDOI →

Why This Matters for Hirudotherapy

Synthesises the reported case evidence for leech therapy in venous congestion, the FDA-cleared indication. In the absence of randomized trials it is intended to guide clinicians when consenting patients; overall complication rate 21.8%.

FDA-Cleared Indication

FDA-cleared indication. Medicinal leeches are FDA 510(k)-cleared for relief of venous congestion following reconstructive surgery.

Last Updated: May 27, 2026Reviewed by: Andrei Dokukin, MD
FDA-cleared microsurgery indicationSystematic review evidence

Scope and methodology

Whitaker et al. conducted a systematic review of leech therapy in plastic and reconstructive surgery, analyzing 277 reported cases from 67 papers (literature searched 1966–2009). Primary outcomes were the reported "success" and "failure" of leech therapy; secondary outcomes were complications, number of leeches, pharmacological adjuncts and blood transfusion.[R1]

Key findings

77.98%

Overall flap salvage rate

88.3%

Salvage without infection

37.4%

Salvage with infection

The infection paradox

A key finding reported by later reviews citing this paper was the large drop in salvage when infection occurred (88.3% to 37.4%). Medicinal leeches carry Aeromonas species in the digestive tract; these bacteria contribute to the digestion of ingested blood. This creates an inherent infection risk during any leech application.

Across 277 cases (PMID 22407551), Whitaker reported a 77.98% (216/277) success rate; 79.05% of cases received antibiotics and the overall complication rate was 21.8%.[R1]

Mechanisms of salvage

Leeches are described as relieving venous congestion through three overlapping mechanisms:

1. Active extraction

Each leech ingests 5–15 mL of blood during feeding, providing immediate mechanical decompression of the congested tissue.

2. Passive oozing

The anticoagulant-rich bite wound continues to ooze after detachment; one review gives 50–100 mL of blood over the 24–48 hours after the leech is detached.

3. Vasodilation

Laser Doppler flowmetry shows a significant increase in superficial skin perfusion around the leech bite.

Clinical implications

The review reports the following outcomes; related recommendations come from later work:

FactorEvidenceRecommendation
Antibiotic prophylaxis79.05% of cases (N = 166) received antibiotics; overall complication rate 21.8%Prophylaxis active against Aeromonas (Herlin 2017: ciprofloxacin plus trimethoprim-sulfamethoxazole)
TimingNot assessed in the abstract; Herlin 2017: optimal application every 2-8 hoursApply every 2–8 hours (Herlin 2017 review)
Monitoring49.75% of cases (N = 101) required blood transfusionMonitor haemoglobin during therapy (complete blood count before treatment)

Application frequency

A subsequent systematic review by Herlin et al. (2017) analyzed 121 articles, took 41 studies into consideration, and added data from 43 of their own patients; leech therapy success ranged from 65 to 85% (83.7% in their series), with optimal application frequency every 2 to 8 hours and an overall duration of 4 to 10 days.

Infection risk is manageable

Aeromonas infection is the primary infectious risk, and antibiotic prophylaxis active against Aeromonas is recommended (Herlin 2017: ciprofloxacin plus trimethoprim-sulfamethoxazole). Prophylaxis does not eliminate infection: at Duke, infectious complications occurred in 7 of 87 patients (8%) despite prophylactic antibiotics.

References

  • [R1]

    The efficacy of medicinal leeches in plastic and reconstructive surgery: a systematic review of 277 reported clinical cases

    Primary source (Whitaker et al., PMID 22407551): 67 papers, 277 reported cases.

  • [R2]

    Leech Therapy in Flap Salvage: Systematic Review and Practical Recommendations

    Annales de Chirurgie Plastique Esthétique(2017)https://doi.org/10.1016/j.anplas.2016.06.004

    Herlin et al. (PMID 27427444): systematic review plus a series of 43 patients; success 65-85% (83.7% in their series), application every 2-8 hours.

  • [R3]

    Outcomes of flap salvage with medicinal leech therapy

    Nguyen MQ et al. (PMID 22473683): retrospective series of 39 patients; 33.3% of regional/free flaps salvaged, 33.3% partially salvaged, 33.3% lost.

Related Resources

Added to ASH library: February 27, 2026 | Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.